Founded
31 Dec 1986
Address
BioCryst Pharmaceuticals Inc
4505 Emperor Blvd
Suite 200
Durham, NC 27703
United States
Website
VCID: 106777
Profile
Corporate information
Official name
BioCryst Pharmaceuticals Incorporated
Registration country
Official name
BioCryst Pharmaceuticals Incorporated
Registration country
Investment activity status
Active investor
Funding
Funding rounds
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Kleiner Perkins Caufield & Byers LLC | Venture capital firm. | United States |
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Johnson & Johnson Innovation LLC | Accelerator of early-stage innovation worldwide that forms collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. | United States |
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
OrbiMed Advisors LLC | American investment firm focused on making public and private investments in the healthcare and biotechnology industries. | United States |
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
TPG Growth LLC | The middle market and growth equity investment platform of TPG. | United States |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
Johnson & Johnson Innovation LLC Accelerator of early-stage innovation worldwide that forms collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. |
+1 (732) 524-3218 |
N/A |
|
|
Kleiner Perkins Caufield & Byers LLC Venture capital firm. |
+1 (650) 233-2750 |
N/A |
|
Noble Financial Group |
+1 (314) 687-1075 |
N/A |
|
|
OrbiMed Advisors LLC American investment firm focused on making public and private investments in the healthcare and biotechnology industries. |
+1 (212) 739-6400 |
N/A |
|
TPG Capital LP Private equity firm |
+1 (415) 743-1500 |
N/A |
|
|
TPG Growth LLC The middle market and growth equity investment platform of TPG. |
+1 (650) 289-5800 |
N/A |
|
Ventana Capital Management LP |
+1 (949) 481-4200 |
N/A |